Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2

Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2

Intelligent Medicine | The Best of High Tech Medicine and Alternative Modalities

B27 juillet 202626 min
Lecture

Dr. Hoffman continues his conversation with physician and molecular biologist Dr. Adrian Woolfson, co-founder of Genyro, a biotechnology company specializing in synthetic genome design and construction, and author of “On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence.”

Épisodes · Intelligent Medicine | The Best of High Tech Medicine and Alternative Modalities